Begona Indakoetxea
San Sebastian, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
Journal: Acta neuropathologica
Published: January 20, 2020
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.
Journal: The Lancet. Neurology
Published: May 21, 2019
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
Journal: Acta neuropathologica
Published: March 23, 2019
Longitudinal Neuropsychological Study of Presymptomatic c.709-1G>A Progranulin Mutation Carriers.
Journal: Journal of the International Neuropsychological Society : JINS
Published: October 30, 2018
Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidβ Are Strongly Associated With Healthy Aging in the Oldest Old.
Journal: Frontiers in aging neuroscience
Published: July 30, 2018
MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.
Journal: Journal of Alzheimer's disease : JAD
Published: October 08, 2015
Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes.
Journal: Neurobiology of aging
Published: April 28, 2014
Neuropsychological features of asymptomatic c.709-1G>A progranulin mutation carriers.
Journal: Journal of the International Neuropsychological Society : JINS
Published: November 20, 2012
Distinctive age-related temporal cortical thinning in asymptomatic granulin gene mutation carriers.
Journal: Neurobiology of aging
Published: March 20, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026